Built on NVIDIA AI, the tools assess eligibility across the CancerLinQ network of nearly 1,000 sites of care and over 13 million patient records. ConcertAI's systems support up to 50% higher trial enrollment.
ConcertAINVIDIA Source: Nvidia news post, published Nov 13, 2026